GEO experienced a CEO transition with J. David Donahue retiring in February 2026, coupled with a substantial deterioration in operating cash flow and facility capacity reduction.
The company is experiencing leadership instability with its second CEO change in just over a year, creating uncertainty around strategic direction and execution. The dramatic decline in operating cash flow from operations, despite maintaining profitability, suggests potential working capital management challenges or timing issues that require close monitoring.
GEO's financial performance shows mixed signals with operating income declining modestly to $257.5M while accounts receivable expanded substantially to $593.5M, contributing to higher current assets. Most concerning is the severe deterioration in operating cash flow, which fell dramatically from $242.2M to $72.6M, indicating potential collection issues or unfavorable working capital movements. The company also reduced its facility footprint from 99 to 95 locations and approximately 79,000 to 75,000 beds, suggesting operational consolidation.
Operating cash flow fell 70% — earnings quality concerns; investigate working capital changes and non-cash items.
Receivables surged 57.8% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Current assets grew 43.7% — improving short-term liquidity or inventory/receivables build.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
Inventory built 14.2% — monitor whether demand supports this build or if write-downs may follow.
Equity base grew 12.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Cash decreased 10.3% — monitor burn rate and upcoming capital needs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →